Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause coronavirus
disease 2019 (COVID-19), an influenza-like disease that is primarily thought to infect the lungs …

The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

The emergence and rapid spread of SARS-CoV-2 variants may affect vaccine efficacy
substantially. The Omicron variant termed BA.2, which differs substantially from BA.1 based on …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), which may result in acute respiratory distress syndrome (ARDS), …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing
to disrupt personal lives, global healthcare systems, and economies. Hence, there is an …

Coronavirus entry is mediated by the spike protein that binds the receptor and mediates
fusion after cleavage by host proteases. The proteases that mediate entry differ between cell …

Transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) between livestock
and humans is a potential public health concern. We demonstrate the susceptibility of rabbits …

Virus propagation methods generally use transformed cell lines to grow viruses from clinical
specimens, which may force viruses to rapidly adapt to cell culture conditions, a process …

Rapid identification of host genes essential for virus replication may expedite the generation
of therapeutic interventions. Genetic screens are often performed in transformed cell lines …

Novel SARS-CoV-2 omicron variants, including BM. 1.1. 1, BQ. 1.1, and XBB. 1, continue to
emerge at an unprecedented rate, evading preexisting immunity from vaccination and …